Table 2

Adjusted hazard ratios with 95% confidence intervals for cardiovascular recurrence and all cause mortality after myocardial infarction in the community, 1993-2001

All cause mortalityNon-fatal myocardial infarction or death from cardiovascular disease
PredictorOverallWomenOlder peopleOverallWomenOlder people
Sex (male v female)1.19 (1.07 to 1.33)to1.15 (1.03 to 1.29)1.11 (1.00 to 1.24)to1.11 (0.99 to 1.25)
Age:
<451.001.00to1.001.00
45-540.96 (0.48 to 1.94)1.40 (0.18 to 11.24)0.99 (0.60 to 1.61)0.55 (0.19 to 1.53)
55-641.58 (0.83 to 3.02)2.91 (0.40 to 21.37)1.26 (0.79 to 2.00)0.79 (0.31 to 2.02)
65-742.57 (1.36 to 4.84)3.26 (0.45 to 23.59)1.59 (1.01 to 2.51)0.79 (0.32 to 1.99)
≥753.57 (1.90 to 6.73)4.50 (0.62 to 32.50)1.90 (1.20 to 2.99)0.95 (0.38 to 2.38)
Deprivation category:
1 (least deprived)1.001.001.001.001.001.00
21.13 (0.89 to 1.43)0.93 (0.66 to 1.32)1.10 (0.86 to 1.40)1.14 (0.90 to 1.430.88 (0.62 to 1.24)1.04 (0.81 to 0.34)
31.18 (0.95 to 1.48)0.92 (0.65 to 1.29)1.19 (0.95 to 1.50)1.12 (0.90 to 1.390.75 (0.53 to 1.06)1.06 (0.84 to 1.35)
41.37 (1.09 to 1.72)1.13 (0.81 to 1.59)1.30 (1.03 to 1.66)1.24 (0.99 to 1.560.92 (0.65 to 1.30)1.13 (0.88 to 1.44)
51.39 (1.09 to 1.78)1.03 (0.70 to 1.50)1.29 (1.00 to 1.68)1.34 (1.06 to 1.71)0.92 (0.63 to 1.36)1.15 (0.88 to 1.50)
6 (most deprived)1.27 (1.01 to 1.60)0.97 (0.68 to 1.37)1.24 (0.97 to 1.58)1.21 (0.97 to 1.52)0.86 (0.60 to 1.21)1.12 (0.88 to 1.44)
Statins0.69 (0.59 to 0.80)0.63 (0.49 to 0.80)0.72 (0.61 to 0.84)0.82 (0.71 to 0.95)0.69 (0.54 to 0.88)0.84 (0.71 to 0.99)
β blockers0.38 (0.33 to 0.43)0.46 (0.37 to 0.56)0.39 (0.34 to 0.45)0.40 (0.35 to 0.46)0.48 (0.39 to 0.59)0.46 (0.40 to 0.53)
Angiotensin converting enzyme inhibitors0.54 (0.48 to 0.61)0.55 (0.45 to 0.66)0.56 (0.50 to 0.64)0.57 (0.50 to 0.64)0.64 (0.53 to 0.78)0.61 (0.54 to 0.70)
Nitrates0.68 (0.61 to 0.77)0.68 (0.57 to 0.82)0.66 (0.58 to 0.75)0.78 (0.69 to 0.88)0.78 (0.65 to 0.94)0.75 (0.65 to 0.85)
Calcium blockers0.76 (0.67 to 0.86)0.74 (0.61 to 0.89)0.73 (0.65 to 0.83)0.79 (0.70 to 0.89)0.75 (0.62 to 0.91)0.76 (0.66 to 0.87)
Antihypertensive drugs1.14 (1.01 to 1.29)0.83 (0.70 to 0.99)1.13 (1.00 to 1.28)0.90 (0.80 to 1.02)0.72 (0.60 to 0.86)0.91 (0.80 to 1.03)
Antiplatelet drugs0.44 (0.39 to 0.50)0.49 (0.41 to 0.58)0.41 (0.36 to 0.47)0.42 (0.37 to 0.47)0.44 (0.37 to 0.53)0.39 (0.34 to 0.45)
Warfarin0.97 (0.84 to 1.14)0.94 (0.74 to 1.20)0.89 (0.75-1.06)0.93 (0.78 to 1.10)0.84 (0.64 to 1.09)0.86 (0.71 to 1.04)
  • Other covariates included in the multivariate analysis: non-steroidal anti-inflammatory drugs, disease modifying antirheumatic drugs, hormone replacement therapy, and oral contraceptives, steroids, previous cardiovascular disease, and comorbidity (diabetes, obstructive airway disease, cancer, renal failure, rheumatoid arthritis).